US Patent Issued to FONTERRA CO-OPERATIVE GROUP on Nov. 11 for "Use of polar lipids to treat or prevent gestational diabetes mellitus" (New Zealander Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,619, issued on Nov. 11, was assigned to FONTERRA CO-OPERATIVE GROUP Ltd. (Auckland, New Zealand).

"Use of polar lipids to treat or prevent gestational diabetes mellitus" was invented by Sophie Yvette Fabienne Christine Gallier (Auckland, New Zealand), Angela Marie Rowan (Auckland, New Zealand) and Philip Newton Baker (Auckland, New Zealand).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating or preventing gestational diabetes mellitus (GDM) and/or treating or preventing one or more GDM-associated risks or one or more sequelae of GDM by administering one or more polar lipids, in addition to uses, compositions, and medicaments comprising...